Menu
0
Total price
0 €
PRICES include / exclude VAT
Homepage>BS EN 14107:2003 Fat and oil derivatives. Fatty acid methyl esters (FAME). Determination of phosphorous content by inductively coupled plasma (ICP) emission spectrometry
sklademVydáno: 2003-05-15
BS EN 14107:2003 Fat and oil derivatives. Fatty acid methyl esters (FAME). Determination of phosphorous content by inductively coupled plasma (ICP) emission spectrometry

BS EN 14107:2003

Fat and oil derivatives. Fatty acid methyl esters (FAME). Determination of phosphorous content by inductively coupled plasma (ICP) emission spectrometry

Format
Availability
Price and currency
Anglicky Secure PDF
Immediate download
150.03 €
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
15.00 €
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
45.01 €
Anglicky Hardcopy
In stock
150.03 €
Označení normy:BS EN 14107:2003
Počet stran:12
Vydáno:2003-05-15
ISBN:0 580 41838 3
Status:Standard
DESCRIPTION

BS EN 14107:2003


This standard BS EN 14107:2003 Fat and oil derivatives. Fatty acid methyl esters (FAME). Determination of phosphorous content by inductively coupled plasma (ICP) emission spectrometry is classified in these ICS categories:
  • 67.200.10 Animal and vegetable fats and oils
This European Standard specifies an inductively coupled plasma (ICP) emission spectrometry method for the determination of phosphorus content between 4 mg/kg and 20 mg/kg in Fatty Acid Methyl Esters, hereinafter referred as FAME. This method aims to evaluate the FAME quality, in terms of transesterification by-products content such as phosphorus, whose concentration may affect the fuel behaviour. WARNING - The use of this method may involve hazardous equipment, materials and operations. This method does not purport to address to all of the safety problems associated with its use, but it is the responsibility of the user to search and establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.